Author

S. Frias

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1

Frequent Co-Authors

A. Rodriguez· 2 shared A. A. G. Gomez· 1 shared A. de la Torre Lujan· 1 shared A. L. Saavedra· 1 shared A. R. Osorio· 1 shared B. T. B. Martinez· 1 shared C. C. Henandez· 1 shared D. A. O. Rico· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Rodriguez

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Prediction of myeloid malignant cells in Fanconi anemia using machine learning

L. A. Flores-Mejia, P. Siliceo-Portugal, I. Garcia-Quezada, U. J. Figueroa, B. T. B. Martinez, D. Sosa, A. R. Osorio, H. Tovar, S. Frias, A. Rodriguez

This study uses machine learning to identify myeloid malignant transcriptional profiles in FA patients' bone marrow using scRNAseq data, achieving high sensitivity and specificity for MDS and AML detection.

bioRxiv · Dec 31, 2023Cancer Biology

Large-scale topological disruption of chromosome territories 9 and 22 is associated with nonresponse to treatment in CML

E. Fabian-Morales, D. G. Vallejo Escamilla, A. A. G. Gomez, A. Rodriguez, R. Gonzalez-Barrios, Y. L. Rodriguez-Torres, C. C. Henandez, A. de la Torre Lujan, D. A. O. Rico, E. C. O. Guzman, A. L. Saavedra, S. Frias, L. A. H. Montalvo

The paper links structural disruption of chromosome territories 9 and 22 in CD34+ cells to TKI resistance in CML patients.

bioRxiv · Jul 1, 2021 · PreprintCancer Biology